Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cellsLuís F.Z. Batista, Steven E. Artandi, Matthew F. Pech et al.|Nature|2011Cited by 260
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenitaFranklin L. Zhong, Steven E. Artandi, Marina Shkreli et al.|Genes & Development|2011Cited by 257
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaSharon A. Savage, Smita Bhatia, Lei Song et al.|JAMA Oncology|2020Cited by 251
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis CongenitaShahinaz M. Gadalla, Sharon A. Savage, Carmem Sales‐Bonfim et al.|Biology of Blood and Marrow Transplantation|2013Cited by 130
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCTAndrew C. Dietz, Blanche P. Alter, Sharon A. Savage et al.|Biology of Blood and Marrow Transplantation|2017Cited by 61